Table 1.
Characteristics of the study population
| Variables | All patients (N = 345) | Endpoints (N = 60) | No endpoints (N = 211) | P‐value |
|---|---|---|---|---|
| Age | 68.1 ± 11.5 | 70.4 ± 10.5 | 67.3 ± 11.7 | 0.069 |
| BMI | 23.8 ± 3.4 | 23.4 ± 3.1 | 24.0 ± 3.4 | 0.264 |
| Gender | ||||
| Male (%) | 234 (67.8) | 41 (68.3) | 147 (69.7) | 0.843 |
| Female (%) | 111 (32.2) | 19 (31.7) | 64 (30.3) | |
| Hypertension (%) | 245 (71.2) | 43 (71.7) | 154 (73.0) | 0.840 |
| Diabetes (%) | 133 (38.6) | 23 (38.3) | 86 (40.8) | 0.735 |
| Dyslipidemia (%) | 269 (78.0) | 50 (83.3) | 161 (76.3) | 0.247 |
| Heart disease history (%) | 78 (22.6) | 22 (36.7) | 41 (19.4) | 0.005 |
| Stroke history (%) | 106 (30.7) | 25 (41.7) | 65 (30.8) | 0.115 |
| TACI/PACI (%) | 235 (68.1) | 44 (73.3) | 150 (71.1) | 0.734 |
| POCI (%) | 149 (43.2) | 28 (46.7) | 83 (39.3) | 0.308 |
| LACI (%) | 39 (11.3) | 9 (15.0) | 25 (11.8) | 0.478 |
| Base | 275 ± 55.6 | 286 ± 59.0 | 272 ± 53.8 | 0.078 |
| PRU | 197 ± 71.6 | 213 ± 74.8 | 191 ± 68.8 | 0.032 |
| PRU>=230(%) | 122 (35.4) | 29 (48.3) | 61 (28.9) | 0.005 |
| %Inhibition | 28.5 ± 23.5 | 26.5 ± 23.6 | 29.6 ± 23.6 | 0.363 |
Data are shown as mean ± SD or absolute and relative frequencies. BMI, body mass index; TACI, total anterior circulation infarction; PACI, partial anterior circulation infarction; POCI, posterior circulation infarction; LACI, lacunar infarction.